Is Ergotocine Maleate Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Ergotocine Maleate? Is Ergotocine Maleate safe for nursing mother and child? Does Ergotocine Maleate extracts into breast milk? Does Ergotocine Maleate has any long term or short term side effects on infants? Can Ergotocine Maleate influence milk supply or can Ergotocine Maleate decrease milk supply in lactating mothers?

• DrLact safety Score for Ergotocine Maleate is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of Ergotocine Maleate may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that Ergotocine Maleate may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using Ergotocine Maleate .
• It is recommended to evaluate the advantage of not breastfeeding while using Ergotocine Maleate Vs not using Ergotocine Maleate And continue breastfeeding.
• While using Ergotocine Maleate Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Ergot derivative which is used in the prevention and treatment of postpartum hemorrhage. It has frequent and serious side effects (nausea, vomiting, headache, hypertension, arrhythmias, angina and infarction) that do not occur with oxytocin, so the latter is preferable to reduce the risk of postpartum hemorrhage.They have occurred serious poisonings in infants when giving it intramuscularly due to confusion with other medication for newborn (Dargaville 1998). Data on excretion into breast milk is lacking; the excretion of another product of the same family and similar chemical structure, Methylergometrine, has been shown to be negligible. It may cause shortening of the duration of breastfeeding (Jordan 2009, Begley 1990) by decreasing the concentration of prolactin and inhibiting lactation (Canales 1976, Shane 1974). These effects have been demonstrated to be much more intense that in the case of Methylergometrine.